• Ivermectin as a Broad-Spectrum Anti-Parasitic in Advanced Re

  2026-07-08

  Ivermectin stands out as a high-purity, broad-spectrum anti-parasitic research compound for experimental protocols requiring robust, reproducible performance. Its precise use in parasitology and translational models enables nuanced investigation of drug mechanisms and host–pathogen interactions.

• RapaLink-1: Precision Control of mTOR for Dormancy and Oncol

  2026-07-07

  Explore how RapaLink-1, a third-generation mTOR inhibitor, enables precise and robust control of mTOR pathways for both embryonic dormancy research and cancer models. This article delivers advanced insights into protocol design, resistance mutation targeting, and practical assay optimization.

• Patient-Derived Gastric Cancer Assembloid Model: Tumor–Strom

  2026-07-07

  This study presents a novel patient-derived gastric cancer assembloid system that integrates matched tumor organoids with stromal subpopulations, closely mimicking the tumor microenvironment. The model provides new opportunities to study tumor–stroma interactions, drug response variability, and resistance mechanisms, advancing the field of personalized preclinical cancer research.

• Allosteric PDK4 Inhibitors: New Scaffolds for Metabolic Dise

  2026-07-06

  The referenced study identifies and characterizes a novel class of allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, with compound 8c demonstrating potent in vitro and in vivo efficacy against metabolic, allergic, and proliferative disease models. These findings provide a validated scaffold for further drug discovery and highlight the therapeutic value of targeting metabolic regulation in disease.

• Bafilomycin C1: Enabling Precision pH Control in iPSC-Based

  2026-07-06

  Discover how Bafilomycin C1, a potent vacuolar H+-ATPases inhibitor, empowers advanced cell-based assays by allowing precise manipulation of intracellular pH. Explore its unique role in high-content phenotypic screening and autophagy research, with insights into iPSC-derived cardiomyocyte models.

• Aprotinin (BPTI): Beyond Fibrinolysis—Redefining Blood Resea

  2026-07-05

  Explore how aprotinin, the bovine pancreatic trypsin inhibitor, uniquely advances blood research by linking serine protease inhibition to red blood cell membrane mechanics. Discover protocol insights and practical implications not covered elsewhere.

• 5X Protein Loading Buffer (Reducing): Technical SDS-PAGE Gui

  2026-07-04

  5X Protein Loading Buffer (Reducing) addresses the need for reliable protein denaturation and reduction of disulfide bonds during SDS-PAGE sample preparation. It is appropriate for workflows requiring accurate protein molecular weight separation under reducing conditions, but should not be used where native conformation or non-reducing analysis is needed.

• Applied Use-Cases of YM-155 Hydrochloride: Survivin Inhibito

  2026-07-03

  YM-155 hydrochloride stands out as a nanomolar-potency survivin inhibitor that enables precision apoptosis research and robust tumor regression modeling. This guide bridges advanced in vitro methodologies with actionable workflows, highlighting protocol enhancements, troubleshooting strategies, and the latest innovations to maximize the impact of YM-155 hydrochloride in cancer research.

• HLY78: Wnt/β-Catenin Pathway Modulator for Precision Researc

  2026-07-03

  HLY78 empowers researchers to activate the Wnt/β-catenin pathway with unprecedented specificity, advancing embryonic development and fibrosis modeling. Its Axin-targeting mechanism enables robust stem cell marker induction and high-fidelity pathway manipulation in both cellular and in vivo workflows.

• Ionomycin Free Acid: Unraveling Calcium Ionophore Mechanisms

  2026-07-02

  Explore the advanced role of Ionomycin free acid as a calcium ionophore in dissecting FAK regulation and intracellular calcium dynamics. This in-depth analysis uniquely connects molecular mechanisms to practical assay design, offering fresh insight beyond standard workflow protocols.

• Deferasirox Fe3+ Chelate: Precision Iron Overload Modeling i

  2026-07-02

  Deferasirox Fe3+ chelate (Exjade) delivers unmatched reproducibility for iron overload treatment research, with robust solubility in DMSO and high assay compatibility. APExBIO’s high-purity formulation empowers nuanced studies of iron metabolism, myeloid differentiation, and ROS signaling.

• Angiotensin 1/2 (5-7): Advanced Use Cases for RAS Research

  2026-07-01

  Angiotensin 1/2 (5-7) offers exceptional purity and solubility, unlocking robust, reproducible workflows for cardiovascular and viral pathogenesis research. This guide details optimized protocols, advanced applications, and real troubleshooting strategies to maximize discovery using this peptide in both hypertension and SARS-CoV-2 receptor studies.

• Genistein in Cytoskeleton-Driven Autophagy & Cancer Workflow

  2026-07-01

  Genistein (5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one) enables precise interrogation of cytoskeleton-dependent autophagy and growth signaling in cancer models. This article details experimental workflows, protocol parameters, and troubleshooting strategies to maximize reproducibility and insight in cell proliferation inhibition and chemoprevention research.

• Glabridin-Gold(I) Complex 6d: Dual TrxR/MAPK Targeting for A

  2026-06-30

  This study introduces a glabridin-gold(I) complex (6d) that enhances antitumor immunity by simultaneously targeting thioredoxin reductase (TrxR) and MAPK pathways. The findings highlight 6d’s role in reshaping the tumor microenvironment by promoting dendritic cell maturation and suppressing immunosuppressive cell populations, offering a promising strategy for combination immunotherapies.

• ABT-199 (Venetoclax) in Apoptosis Assays: Protocols & Insigh

  2026-06-30

  ABT-199 (Venetoclax) stands out for its unrivaled selectivity and potency in Bcl-2-dependent apoptosis research, driving advances in both hematologic and emerging solid tumor models. This article dissects practical protocols, troubleshooting, and the latest cross-validated applications, empowering researchers to optimize experimental design.

451 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page